Journal
JOURNAL OF BIOPHARMACEUTICAL STATISTICS
Volume 17, Issue 6, Pages 965-995Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/10543400701643848
Keywords
dose-finding; dose-response; flexible designs; modeling; phase II trials; proof of concept; target dose
Categories
Ask authors/readers for more resources
Inadequate selection of the dose to bring forward in confirmatory trials has been identified as one of the key drivers of the decreasing success rates observed in drug development programs across the pharmaceutical industry. In recognition of this problem, the Pharmaceutical Research and Manufacturers of America (PhRMA), formed a working group to evaluate and develop alternative approaches to dose finding, including adaptive dose- ranging designs. This paper summarizes the work of the group, including the results and conclusions of a comprehensive simulation study, and puts forward recommendations on how to improve dose ranging in clinical development, including, but not limited to, the use of adaptive dose- ranging methods.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available